quinelorane has been researched along with oxidopamine in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bloch, B; Fourreau, L; Fredholm, BB; Gonon, F; Le Moine, C; Svenningsson, P | 1 |
| Brocco, M; Chaput, C; Cussac, D; Millan, MJ; Newman-Tancredi, A; Pasteau, V; Rivet, JM; Touzard, M | 1 |
| Hiratochi, M; Ijiro, T; Kaidoh, K; Oana, F; Suzuki, T; Tsuchioka, A; Yamauchi, Y | 1 |
3 other study(ies) available for quinelorane and oxidopamine
| Article | Year |
|---|---|
Opposite tonic modulation of dopamine and adenosine on c-fos gene expression in striatopallidal neurons.
Topics: Adenosine; Animals; Antiparkinson Agents; Corpus Striatum; Dopamine; Dopamine Agonists; Drug Design; Gene Expression Regulation; Genes, fos; Globus Pallidus; In Situ Hybridization; Male; Models, Neurological; Nerve Tissue Proteins; Neurons; Oxidopamine; Proto-Oncogene Proteins c-fos; Purinergic P1 Receptor Antagonists; Pyrimidines; Quinolines; Rats; Rats, Wistar; Receptor, Adenosine A2A; Receptors, Dopamine D2; RNA, Messenger; Triazoles; Tyrosine 3-Monooxygenase | 1999 |
Dopamine D2 receptor-mediated G-protein activation in rat striatum: functional autoradiography and influence of unilateral 6-hydroxydopamine lesions of the substantia nigra.
Topics: Animals; Autoradiography; Binding, Competitive; Biotransformation; Brain Chemistry; Dopamine; Dopamine Agonists; Dopamine Antagonists; GTP-Binding Proteins; Guanosine 5'-O-(3-Thiotriphosphate); Humans; Neostriatum; Oxidopamine; Quinolines; Rats; Receptors, Dopamine D2; Receptors, Dopamine D3; Recombinant Proteins; Stereotyped Behavior; Substantia Nigra; Sympathectomy, Chemical; Sympatholytics | 2001 |
Duration of drug action of dopamine D2 agonists in mice with 6-hydroxydopamine-induced lesions.
Topics: Animals; Antiparkinson Agents; Apomorphine; Azepines; Benzothiazoles; Cabergoline; Corpus Striatum; Disease Models, Animal; Dopamine Agonists; Ergolines; Indoles; Injections, Intraventricular; Male; Mice; Motor Activity; Oxidopamine; Parkinsonian Disorders; Pramipexole; Quinolines; Receptors, Dopamine D2; Tetrahydronaphthalenes; Thiophenes | 2015 |